Connect
MJA
MJA

Ultrasound as a treatment modality for neurological diseases

Gerhard Leinenga, Rebecca M Nisbet and Jürgen Götz
Med J Aust 2017; 206 (11): 470-471. || doi: 10.5694/mja16.01013

Neurological disorders are a particular challenge for therapeutic intervention — ultrasound has emerged as a novel approach with a broad range of applications

With an ageing population, neurological disorders present an increasing challenge to our health care systems. Although antibodies are increasingly being explored for therapeutic intervention,1 the inefficiency of their uptake by the brain means that the estimated cost of a vaccine to treat neurodegenerative disorders such as Alzheimer disease (AD) will exceed US$25 000 per patient per year.2 Not only is this expected to challenge the health care systems of many countries, it also raises ethical issues associated with making these vaccines available to every patient.

  • Gerhard Leinenga
  • Rebecca M Nisbet
  • Jürgen Götz

  • Queensland Brain Institute, University of Queensland, Brisbane, QLD

Correspondence: j.goetz@uq.edu.au

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.